Add to ORKGBarkhof, F. [Promotor]Scheltens, P. [Promotor]Visser, P.J. [Copromotor]Tijms, B.M. [Copromotor
Alzheimer’s disease (AD) is the most common form of neurodegenerative dementia. Researchers have lon...
The paper provides data on current neuroimaging techniques for diagnosing Alzheimer’s disease and va...
Scheltens, P. [Promotor]Lammertsma, A.A. [Promotor]Flier, W.M. van der [Copromotor]Berckel, B.N.M. v...
Flier, W.M. van der [Promotor]Berckel, B.N.M. van [Promotor]Tijms, B.M. [Copromotor
Barkhof, F. [Promotor]Scheltens, P. [Promotor]Berckel, B.N.M. van [Copromotor]Wink, A.M. [Copromotor
Alzheimer’s disease (AD) is a neurodegenerative disease causing progressive cognitive decline until ...
Alzheimer’s disease (AD) starts at a molecular level possibly decades earlier than could be detected...
Abstract Several neuroimaging techniques are promising tools as early markers of brain pathology in ...
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for se...
The neuropathological hallmarks of Alzheimer disease (AD) include “positive ” lesions such as amyloi...
Several neuroimaging biomarkers have been identified to diagnose Alzheimer’s disease (AD) since the ...
© 2016 Elsevier GmbH The current gold standard for the diagnosis of Alzheimer's disease (AD) is the ...
Alzheimer disease (AD), the most common cause of dementia in the elderly, is a progressive neurodege...
This thesis focuses on early and differential diagnosis of Alzheimer’s disease (AD) using multimodal...
The revised NIA-AA diagnostic criteria for Alzheimer’s disease (AD) and mild cognitive impairment (M...
Alzheimer’s disease (AD) is the most common form of neurodegenerative dementia. Researchers have lon...
The paper provides data on current neuroimaging techniques for diagnosing Alzheimer’s disease and va...
Scheltens, P. [Promotor]Lammertsma, A.A. [Promotor]Flier, W.M. van der [Copromotor]Berckel, B.N.M. v...
Flier, W.M. van der [Promotor]Berckel, B.N.M. van [Promotor]Tijms, B.M. [Copromotor
Barkhof, F. [Promotor]Scheltens, P. [Promotor]Berckel, B.N.M. van [Copromotor]Wink, A.M. [Copromotor
Alzheimer’s disease (AD) is a neurodegenerative disease causing progressive cognitive decline until ...
Alzheimer’s disease (AD) starts at a molecular level possibly decades earlier than could be detected...
Abstract Several neuroimaging techniques are promising tools as early markers of brain pathology in ...
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for se...
The neuropathological hallmarks of Alzheimer disease (AD) include “positive ” lesions such as amyloi...
Several neuroimaging biomarkers have been identified to diagnose Alzheimer’s disease (AD) since the ...
© 2016 Elsevier GmbH The current gold standard for the diagnosis of Alzheimer's disease (AD) is the ...
Alzheimer disease (AD), the most common cause of dementia in the elderly, is a progressive neurodege...
This thesis focuses on early and differential diagnosis of Alzheimer’s disease (AD) using multimodal...
The revised NIA-AA diagnostic criteria for Alzheimer’s disease (AD) and mild cognitive impairment (M...
Alzheimer’s disease (AD) is the most common form of neurodegenerative dementia. Researchers have lon...
The paper provides data on current neuroimaging techniques for diagnosing Alzheimer’s disease and va...
Scheltens, P. [Promotor]Lammertsma, A.A. [Promotor]Flier, W.M. van der [Copromotor]Berckel, B.N.M. v...